February Full Approvals
This article was originally published in Pharmaceutical Approvals Monthly
Full approvals of NDAs and BLAs.
You may also be interested in...
Alnylam’s Givlaari for acute hepatic porphyria is also among the 14 new products that could get an EU approval recommendation this week.